Search Results 1101-1110 of 21337 for anti-TNF drugs

1. Use of weight-loss pharmacotherapy in patients with cirrhosis and in liver transplant recipients - Mayo Clinic

   More data is needed to establish the safety and efficacy of these agents in the pretransplant and post-transplant settings.

2. Spesolimab-Sbzo (Intravenous Route, Subcutaneous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

   Patients who have received infliximab, adalimumab or certolizumab pegol ≤ 8 weeks before the first administration of study drug; Patients with certain ...

4. Triamterene And Hydrochlorothiazide (Oral Route) Proper Use - Mayo Clinic

   In addition to the use of this medicine, treatment for your high blood pressure may include weight control and changes in the types of foods you eat, ...

5. Anticholinergics And Antispasmodics (Oral Route, Parenteral Route, Rectal Route, Transdermal Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

6. Mogamulizumab-Kpkc (Intravenous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Poteligeo. Descriptions. Mogamulizumab-kpkc injection is ...

7. Articaine And Epinephrine (Injection Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. Danazol (Oral Route) Precautions - Mayo Clinic

   Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines ...

9. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

   To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...

10. Momelotinib (Oral Route) Precautions - Mayo Clinic

    Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control during treatment and for 1 week after the last ...